Using plain language eases patients' fearsPublic's perception of condition was worse when discussed in specialized terms only Waits for transfer to alternate care growingBed-block rates vary across the country, with Ontario facing the largest burden WMA launches physician leadership course Yukon MDs get 3% fee hike in each of four years Agfa gets $29.6m grant from Ontario Supports creation of 100 new IT jobs Alberta report helps inform patients People encouraged to ask questions Motorola solution for Montreal hospital Wireless LAN system supports mobility Preventing postnatal depression Peer support proves effective Telus acquires RPM solution Remote patient monitoring by New IT Winchester selects Toshiba system Diagnostic digital imaging centre Alvesco approved for children Nycomed's Alvesco (ciclesonide inhalation aerosol) is now approved for the management of asthma in children six to 11 years of age. Apidra: new short-acting insulin analogue Sanofi-Aventis is introducing Apidra (insulin glulisine 100 units/mL), a new rapid-acting recombinant human insulin analogue. First Previous 2004 2005 2006 2007 2008 Next Last
